Tegafur-Gimeracil-Oteracil

DRUG4 trials

Sponsors

Zhejiang Cancer Hospital, National Taiwan University Hospital, Fudan University, Zhejiang University

Conditions

AdenocarcinomaAdjuvant TherapyChemoradiotherapyChemotherapy EffectEsophagogastric Junction DisorderGastrectomyImmunotherapyLocally Advanced Gastric Adenocarcinoma

Phase 2

Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis

Zhejiang Cancer HospitalNasopharyngeal Carcinoma

Start: 2018-12-14End: 2022-12-31Target: 220Updated: 2021-06-23

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

National Taiwan University HospitalStage IV Pancreatic Cancer

Start: 2020-07-01End: 2022-12-31Target: 38Updated: 2020-05-06

Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer

TerminatedNCT05161572

Fudan UniversityAdenocarcinoma, Adjuvant Therapy, Chemoradiotherapy +5

Start: 2021-09-28End: 2022-09-30Updated: 2025-06-18

Phase 3

Study of Comparing of With and Without Sequential Therapy of S-1

RecruitingNCT05813015

Zhejiang UniversityChemotherapy Effect, Locally Advanced Gastric Adenocarcinoma

Start: 2023-01-28End: 2026-12-31Target: 70Updated: 2023-04-14

Related Papers

Incorporating nivolumab with preceded gemcitabine and S-1 chemotherapy for patients of metastatic pancreatic cancer: a pilot study.

2025-09-25

A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing study.

2022-06-281 citations